Ya Gao

Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas

Martin J. van den Bent, Ya Gao, Melissa Kerkhof et al. · Neuro-Oncology · 2015 · 173 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Lale Erdem‐Eraslan, Martin J. van den Bent, Youri Hoogstrate et al. · Cancer Research · 2016 · 99 citations · Full text

Medicine, Molecular Medicine, Oncology +17

PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients

Kaspar Draaisma, Maarten M.J. Wijnenga, Bas Weenink et al. · Acta Neuropathologica Communications · 2015 · 67 citations · Full text

Medicine, Molecular Genetics, Oncology +17

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth

Mengmeng Niu, Jing Xu, Yang Liu et al. · Nature Communications · 2021 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

Ya Gao, Bas Weenink, Martin J. van den Bent et al. · European Journal of Cancer · 2018 · 39 citations

Medicine, Cancer Biology, Oncology +15